Clinical trial
Efficacy and Safety of Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.
NCT05990894 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2020
- Completion date
- July 31, 2024
- Enrollment
- 170 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral venous thrombosis